Todd Christopher Longsworth is CLO at NovoCure Ltd (NVCR). They have made 18 open-market trades across 1 company since 2018, most recently 2022-03-08.
CIK 0001693530
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 18 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NVCR | 62,462 | $879K |
Shares reported on the most recent Form 4, priced at the 2022-03-09 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NVCR | SELL | 2022-03-08 | 2022-03-09 | $70.10 | $328K | +8.0% | +18.3% | +7.9% |
| NVCR | SELL | 2022-03-03 | 2022-03-07 | $71.30 | $359K | +12.5% | +25.0% | +15.6% |
| NVCR | SELL | 2021-03-08 | 2021-03-10 | $130.81 | $629K | +6.1% | -0.1% | +58.8% |
| NVCR | SELL | 2021-03-04 | 2021-03-08 | $137.55 | $848K | +5.1% | +0.5% | +59.8% |
| NVCR | SELL | 2021-03-02 | 2021-03-04 | $152.05 | $716K | +8.8% | -0.9% | +55.3% |
| NVCR | SELL | 2021-01-15 | 2021-01-19 | $172.22 | $18.5M | -5.2% | +3.5% | +12.5% |
| NVCR | SELL | 2020-03-06 | 2020-03-10 | $69.53 | $348K | -16.6% | -2.0% | -1.9% |
| NVCR | SELL | 2020-02-28 | 2020-03-02 | $72.22 | $382K | -10.2% | -14.0% | -11.6% |
| NVCR | SELL | 2020-02-25 | 2020-02-26 | $81.16 | $1.4M | -3.7% | -10.3% | -11.8% |
| NVCR | SELL | 2019-09-03 | 2019-09-05 | $87.87 | $13.9M | -6.6% | -13.8% | +1.7% |
| NVCR | SELL | 2019-09-03 | 2019-09-05 | $87.88 | $14.0M | -6.6% | -13.8% | +1.7% |
| NVCR | SELL | 2019-02-28 | 2019-03-01 | $53.68 | $254K | -8.4% | -15.1% | -4.2% |
| NVCR | SELL | 2019-02-25 | 2019-02-26 | $53.63 | $1.0M | -8.8% | -10.5% | +1.6% |
| NVCR | SELL | 2019-01-24 | 2019-01-28 | $49.38 | $1.9M | +3.1% | +12.4% | -6.4% |
| NVCR | SELL | 2019-01-16 | 2019-01-18 | $45.15 | $677K | +6.6% | +15.4% | -8.2% |
| NVCR | SELL | 2019-01-09 | 2019-01-11 | $40.15 | $602K | +13.9% | +19.0% | +7.9% |
| NVCR | SELL | 2018-02-23 | 2018-02-26 | $19.83 | $261K | +3.8% | +0.7% | +45.6% |
| NVCR | SELL | 2018-01-29 | 2018-01-31 | $24.00 | $279K | -7.9% | -2.9% | +24.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.